Literature DB >> 3109813

Comparison of progressive exercise performance of normal subjects and patients with primary pulmonary hypertension.

G E D'Alonzo, L A Gianotti, R L Pohil, R R Reagle, S L DuRee, F Fuentes, D R Dantzker.   

Abstract

The extent of exercise limitation and the mechanisms for that limitation in 11 patients with primary pulmonary hypertension (PPH) were studied by progressive, upright cycle ergometry. All patients had a mean pulmonary artery pressure of 30 mm Hg or higher (mean, 56 +/- 15), normal pulmonary function testing, normal pulmonary capillary wedge pressure, and pulmonary angiography consistent with the diagnosis. Rest and exercise data obtained from the patients with PPh were compared with data obtained from 11 matched, sedentary control subjects. Mean maximal oxygen consumption (VO2) was 13 +/- 4 ml/kg/min in the PPH group compared with 28 +/- 7 ml/kg/min in the controls. At maximal VO2 the minute ventilation (VE) was similar; however, the VE at any level of carbon dioxide production (VCO2) during rest and exercise was significantly higher in the PPH group. Maximal heart rate and oxygen pulse (VO2/heart rate) was significantly higher in the control group (148 +/- 18 vs 180 +/- 24, and 6.3 +/- 2.2 vs 9.9 +/- 3.9, respectively). Anaerobic threshold occurred earlier during progressive exercise in the PPH group and correlated positively with the maximal oxygen pulse achieved in patients with PPH. In conclusion, patients with PPH have severe exertional limitation due to cardiovascular factors with an inability to maintain appropriate oxygen delivery to the body during exercise. No respiratory impairment was recognized; however, an exaggerated ventilatory response to exercise at any level of VCO2 was found.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109813     DOI: 10.1378/chest.92.1.57

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension.

Authors:  G Valli; C D Vizza; P Onorati; R Badagliacca; R Ciuffa; R Poscia; F Brandimarte; F Fedele; P Serra; P Palange
Journal:  Eur J Appl Physiol       Date:  2007-11-03       Impact factor: 3.078

Review 2.  Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Authors:  Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie
Journal:  Expert Rev Respir Med       Date:  2011-04       Impact factor: 3.772

3.  Kinetics of skeletal muscle O2 delivery and utilization at the onset of heavy-intensity exercise in pulmonary arterial hypertension.

Authors:  Priscila B Barbosa; Eloara M V Ferreira; Jaquelina S O Arakaki; Luciana S Takara; Juliana Moura; Rúbia B Nascimento; Luiz E Nery; J Alberto Neder
Journal:  Eur J Appl Physiol       Date:  2011-01-12       Impact factor: 3.078

4.  Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension.

Authors:  N Nagaya; Y Shimizu; T Satoh; H Oya; M Uematsu; S Kyotani; F Sakamaki; N Sato; N Nakanishi; K Miyatake
Journal:  Heart       Date:  2002-04       Impact factor: 5.994

5.  The combination of exercise and respiratory training improves respiratory muscle function in pulmonary hypertension.

Authors:  Hans-Joachim Kabitz; Hinrich-Cordt Bremer; Anja Schwoerer; Florian Sonntag; Stephan Walterspacher; David Johannes Walker; Nicola Ehlken; Gerd Staehler; Wolfram Windisch; Ekkehard Grünig
Journal:  Lung       Date:  2013-12-13       Impact factor: 2.584

6.  Pulmonary capillary hemangiomatosis: the role of invasive cardiopulmonary exercise testing.

Authors:  Hilary M DuBrock; Richard L Kradin; Josanna M Rodriguez-Lopez; Richard N Channick
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

7.  Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension.

Authors:  Leighton Chan; Lisa M K Chin; Michelle Kennedy; Joshua G Woolstenhulme; Steven D Nathan; Ali A Weinstein; Gerilynn Connors; Nargues A Weir; Bart Drinkard; James Lamberti; Randall E Keyser
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

8.  Effect of vitamin D supplementation on cardiovascular disease risk factors and exercise performance in healthy participants: a randomized placebo-controlled preliminary study.

Authors:  Emad A S Al-Dujaili; Nimrah Munir; Raquel Revuelta Iniesta
Journal:  Ther Adv Endocrinol Metab       Date:  2016-06-20       Impact factor: 3.565

9.  Ventilatory efficiency slope correlates with functional capacity, outcomes, and disease severity in pediatric patients with pulmonary hypertension.

Authors:  Christopher M Rausch; Amy Lynne Taylor; Hayley Ross; Stefan Sillau; D Dunbar Ivy
Journal:  Int J Cardiol       Date:  2013-10-11       Impact factor: 4.164

10.  Imitators of exercise-induced bronchoconstriction.

Authors:  Pnina Weiss; Kenneth W Rundell
Journal:  Allergy Asthma Clin Immunol       Date:  2009-11-17       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.